in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Strategies for Generic and Branded Drug Firms Converge
11:17 AM MDT | October 3, 2007 | Alex Scott
Generics drug companies and branded drug producers are reassessing their respective manufacturing strategies in light of tightening competition in the sector, according to a recent report by Enrico T. Polastro, v.p. and senior industry specialist at Arthur D. Little Benelux (Brussels). Generics firms typically outsource their bulk manufacturing, and branded drug producers retain much of their manufacturing in-house, Polastro says. However, the two distinct models have started to converge as producers attempt to gain a competitive edge through enhanced bulk...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee